Manufacturers Life Insurance Company, The Nektar Therapeutics Transaction History

Manufacturers Life Insurance Company, The

  • $100 Billion
  • Q1 2025

A detailed history of Manufacturers Life Insurance Company, The transactions in Nektar Therapeutics stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 64,853 shares of NKTR stock, worth $1.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,853
Previous 65,071 0.34%
Holding current value
$1.67 Million
Previous $60,000 26.67%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$0.66 - $1.19 $143 - $259
-218 Reduced 0.34%
64,853 $44,000
Q4 2024

Feb 14, 2025
SELL
$0.9 - $1.45 $1,032 - $1,663
-1,147 Reduced 1.73%
65,071 $60,000
Q3 2024

Nov 13, 2024
BUY
$1.11 - $1.48 $73,501 - $98,002
66,218 New
66,218 $86,000
Q2 2023

Aug 11, 2023
SELL
$0.53 - $1.03 $38,692 - $75,194
-73,004 Closed
0 $0
Q4 2022

Aug 11, 2023
BUY
$2.03 - $4.28 $822 - $1,733
405 Added 0.56%
73,004 $164,000
Q4 2022

Feb 13, 2023
BUY
$2.03 - $4.28 $822 - $1,733
405 Added 0.56%
73,004 $164,000
Q3 2022

Aug 11, 2023
SELL
$3.04 - $5.14 $7,463 - $12,618
-2,455 Reduced 3.27%
72,599 $232,000
Q3 2022

Nov 03, 2022
SELL
$3.04 - $5.14 $7,463 - $12,618
-2,455 Reduced 3.27%
72,599 $232,000
Q2 2022

Aug 11, 2023
BUY
$3.17 - $6.17 $6,498 - $12,648
2,050 Added 2.81%
75,054 $285,000
Q2 2022

Aug 15, 2022
BUY
$3.17 - $6.17 $237,921 - $463,083
75,054 New
75,054 $285,000
Q4 2021

Feb 16, 2022
SELL
$10.83 - $18.41 $2.29 Million - $3.9 Million
-211,621 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$13.07 - $18.84 $156,931 - $226,211
12,007 Added 6.02%
211,621 $3.8 Million
Q2 2021

Aug 12, 2021
SELL
$16.52 - $20.4 $78,783 - $97,287
-4,769 Reduced 2.33%
199,614 $3.43 Million
Q1 2021

May 03, 2021
SELL
$16.56 - $25.46 $196,120 - $301,522
-11,843 Reduced 5.48%
204,383 $4.09 Million
Q4 2020

Feb 12, 2021
SELL
$15.77 - $19.03 $287,944 - $347,468
-18,259 Reduced 7.79%
216,226 $3.68 Million
Q3 2020

Nov 09, 2020
SELL
$16.59 - $24.79 $68,334 - $102,110
-4,119 Reduced 1.73%
234,485 $3.89 Million
Q2 2020

Aug 10, 2020
SELL
$16.86 - $23.44 $225,924 - $314,096
-13,400 Reduced 5.32%
238,604 $5.35 Million
Q1 2020

May 15, 2020
BUY
$14.47 - $27.96 $73,912 - $142,819
5,108 Added 2.07%
252,004 $4.5 Million
Q4 2019

Feb 14, 2020
BUY
$15.87 - $23.12 $1.23 Million - $1.79 Million
77,382 Added 45.65%
246,896 $5.33 Million
Q3 2019

Nov 12, 2019
BUY
$16.91 - $36.27 $152,240 - $326,538
9,003 Added 5.61%
169,514 $3.04 Million
Q2 2019

Aug 14, 2019
SELL
$31.0 - $36.3 $367,722 - $430,590
-11,862 Reduced 6.88%
160,511 $5.71 Million
Q1 2019

May 13, 2019
BUY
$31.58 - $46.35 $5,431 - $7,972
172 Added 0.1%
172,373 $5.79 Million
Q4 2018

Feb 14, 2019
SELL
$30.43 - $56.65 $125,797 - $234,191
-4,134 Reduced 2.34%
172,201 $5.66 Million
Q3 2018

Nov 14, 2018
BUY
$46.46 - $68.49 $116,150 - $171,225
2,500 Added 1.44%
176,335 $10.7 Million
Q2 2018

Aug 14, 2018
SELL
$46.25 - $104.45 $4.36 Million - $9.86 Million
-94,366 Reduced 35.18%
173,835 $8.49 Million
Q1 2018

May 15, 2018
BUY
$57.4 - $108.44 $8.94 Million - $16.9 Million
155,749 Added 138.5%
268,201 $28.5 Million
Q4 2017

Feb 08, 2018
SELL
$23.02 - $60.5 $3,015 - $7,925
-131 Reduced 0.12%
112,452 $6.72 Million
Q3 2017

Nov 14, 2017
BUY
$17.79 - $24.0 $2 Million - $2.7 Million
112,583
112,583 $2.7 Million

Others Institutions Holding NKTR

# of Institutions
168
Shares Held
123M
Call Options Held
1.18M
Put Options Held
64.6K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $4.83B
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email